Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniil Mudryak"'
Autor:
Ilya Klabukov, Maksim Balyasin, Olga Krasilnikova, Timur Tenchurin, Alexander Titov, Mikhail Krasheninnikov, Daniil Mudryak, Yana Sulina, Alexey Shepelev, Sergei Chvalun, Tatiana Dyuzheva, Anna Yakimova, Dmitry Sosin, Alexey Lyundup, Denis Baranovskii, Peter Shegay, Andrey Kaprin
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 2, p 1399 (2023)
Insufficient vascular growth in the area of artificial-material implantation contributes to ischemia, fibrosis, the development of bacterial infections, and tissue necrosis around the graft. The purpose of this study was to evaluate angiogenesis afte
Externí odkaz:
https://doaj.org/article/525891b462e14c6c971ec8f8d3e4e353
Autor:
Alexey Fayzullin, Semyon Churbanov, Natalia Ignatieva, Olga Zakharkina, Mark Tokarev, Daniil Mudryak, Yana Khristidis, Maxim Balyasin, Alexandr Kurkov, Elena N. Golubeva, Nadejda A. Aksenova, Tatyana Dyuzheva, Peter Timashev, Anna Guller, Anatoly Shekhter
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 853 (2021)
Peri-implant fibrosis (PIF) increases the postsurgical risks after implantation and limits the efficacy of the implantable drug delivery systems (IDDS). Pirfenidone (PF) is an oral anti-fibrotic drug with a short (0) and PLA0 with an equivalent singl
Externí odkaz:
https://doaj.org/article/df8adf73150d4159ac7d0bc5c1de1696
Autor:
Alexey Fayzullin, Natalia Ignatieva, Olga Zakharkina, Mark Tokarev, Daniil Mudryak, Yana Khristidis, Maxim Balyasin, Alexandr Kurkov, Semyon Churbanov, Tatyana Dyuzheva, Peter Timashev, Anna Guller, Anatoly Shekhter
Publikováno v:
Biology, Vol 10, Iss 2, p 136 (2021)
Mature hypertrophic scars (HSs) remain a challenging clinical problem, particularly due to the absence of biologically relevant experimental models as a standard rabbit ear HS model only reflects an early stage of scarring. The current study aims to
Externí odkaz:
https://doaj.org/article/28d18172c49c4a3b84977d0a00bd7475
Autor:
O. L. Zakharkina, Alexey L. Fayzullin, Natalia Yu. Ignatieva, Daniil Mudryak, Peter S. Timashev, Yana Khristidis, N. A. Aksenova, Anatoly B. Shekhter, Elena N. Golubeva, M. V. Balyasin, T. G. Dyuzheva, Anna Guller, S. N. Churbanov, Mark Tokarev, A. V. Kurkov
Publikováno v:
Biomedicines
Volume 9
Issue 8
Biomedicines, Vol 9, Iss 853, p 853 (2021)
Volume 9
Issue 8
Biomedicines, Vol 9, Iss 853, p 853 (2021)
Peri-implant fibrosis (PIF) increases the postsurgical risks after implantation and limits the efficacy of the implantable drug delivery systems (IDDS). Pirfenidone (PF) is an oral anti-fibrotic drug with a short (<
3 h) circulation half-life
3 h) circulation half-life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d597d41409923db8a2f67b3c5ae700b4
https://doi.org/10.3390/biomedicines9080853
https://doi.org/10.3390/biomedicines9080853